Predicting disease effect on the pharmacokinetics (PK) of sustained and immediate release formulations by applying physiologically based pharmacokinetic (PBPK) modellingEDCPT 2023. Poster PA-298 p.98 Eriksson J, Sjögren E, Gillon J-Y, Goyal V, Satam V, Robinson S, Caplain H, Ribeiro I, Chenel M.Pharmetheus Affiliates Senior Director, MIDD ConsultantJohanna ErikssonSee bio Principal Director, PBPK & PBBM Scientific LeadErik SjögrenSee bio Chief Research OfficerMarylore ChenelSee bio
